$2.37-0.11 (-4.25%)
LifeMD, Inc.
LifeMD, Inc. in the Healthcare sector is trading at $2.38 with a market capitalization of $154M. Wall Street consensus targets $8.12 (8 analysts), implying a +242.1% move over the next 12 months. The stock is currently near its 52-week low of $2.35, remaining 36.8% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the distress zone. Risk note: RSI 18 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $47.28M↓ | $50.16M↑ | $7.08M↓ | $60.17M↑ | $49.02M |
| Gross Profit | $42.00M↓ | $44.24M↑ | $2.85M↓ | $52.76M↑ | $42.18M |
| Operating Income | -$7.13M↑ | -$8.93M↓ | -$6.22M↓ | -$1.97M↑ | -$2.35M |
| Net Income | -$7.08M↑ | -$8.87M↓ | $19.96M↑ | -$3.81M↓ | -$1.62M |
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platf...